Target intelligence / Profile preview

DNA topoisomerase 2-DNA cleavage complex (TOP2cc)

Target
TOP2cc
Molecular classification
Enzyme, Type II topoisomerase, DNA-protein complex, Nuclear protein
01

Overview

DNA topoisomerase 2 (TOP2) is a critical nuclear enzyme that regulates DNA topology by generating transient double-strand breaks to allow the passage of one DNA duplex through another, a process essential for replication, transcription, and chromosome segregation [2, 4]. The DNA topoisomerase 2-DNA cleavage complex (TOP2cc) is the specific catalytic intermediate where the enzyme is covalently tethered to the 5' ends of the broken DNA [3, 19]. This complex is the primary pharmacological target for 'topoisomerase II poisons' such as etoposide and anthracyclines, which stabilize the TOP2cc and prevent DNA re-ligation [1, 16]. The resulting accumulation of protein-blocked DNA breaks is highly cytotoxic to rapidly dividing cancer cells, making it a cornerstone of various chemotherapy regimens [5, 11]. However, the stabilization of these complexes can also lead to chromosomal translocations and off-target effects, such as cardiotoxicity and secondary leukemias, particularly when the TOP2B isoform is involved [10, 17, 20].

Other names
Topoisomerase II-DNA covalent complexTopoisomerase II-cleavable complexTOP2-DNA complexDNA topoisomerase (ATP-hydrolyzing) cleavage complex
02

Mechanism of action

Topoisomerase II poisons stabilize the transient covalent intermediate formed between the enzyme and DNA (the cleavage complex), preventing the re-ligation of the double-strand break. This leads to the accumulation of permanent DNA breaks, which stall replication and transcription machinery, ultimately triggering programmed cell death (apoptosis).

03

Biological functions

DNA replicationTranscriptionChromosome segregationChromosome condensationDNA recombinationRelief of DNA torsional stress
04

Disease associations

CancerTherapy-related acute myeloid leukemiaNeurodevelopmental disorders
05

Safety considerations

MyelosuppressionCardiotoxicity (primarily associated with TOP2B inhibition)Secondary malignancies (e.g., treatment-related leukemia)Genotoxicity
06

Interacting drugs

Etoposide

9 more in the full profile.

07

Biomarkers

TOP2A expression levelsTOP2cc levels (measured by RADAR or flow cytometry)MLL gene translocations (11q23)Ki-67 proliferation index

Beyond the preview

Go deeper on DNA topoisomerase 2-DNA cleavage complex (TOP2cc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA topoisomerase 2-DNA cleavage complex (TOP2cc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call